Cleared Traditional

Millipede 088 Access Catheter (K214048) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K214048 · Perfuze, Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2022
Decision
267d
Days
Class 2
Risk

K214048 is an FDA 510(k) clearance for the Millipede 088 Access Catheter. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Perfuze, Ltd. (Galway, IE). The FDA issued a Cleared decision on September 20, 2022 after a review of 267 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Perfuze, Ltd. devices

Submission Details

510(k) Number K214048 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2021
Decision Date September 20, 2022
Days to Decision 267 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
119d slower than avg
Panel avg: 148d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K214048.
BENCHMARK BMX81 Access System
K221822 · Penumbra, Inc. · Nov 2022
Branchor Balloon Guide Catheter
K221951 · Asahi Intecc Co., Ltd. · Oct 2022
Route 92 Medical Full Length 070 Access System
K222743 · Route 92 Medical, Inc. · Oct 2022
Benchmark BMX96 Access System
K213390 · Penumbra, Inc. · Aug 2022
Minjie Catheter System
K212288 · Kai Medtech, LLC · Jun 2022
Distal Access Catheter
K213065 · Guangzhou Easycess Medical Co.,Ltd · May 2022